Nuevocor

Singapore, Singapore · Founded 2020 · Privately Held (backing)

Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. Nuevocor is based in Singapore, Singapore and was founded in 2020. Its last reported valuation was $30.1 million in Nov 2022. It has raised $80.6 million.

Last reported valuation
$30.1M
Oct 2026
Priced at
—
Total raised
$80.6M
Last round
—

Who backs Nuevocor?

12 investors
InvestorType
EDBIVenture capital
SEEDS CapitalVenture capital
Highlight CapitalOther
Kurma PartnersVenture capital
Boehringer Ingelheim Venture FundOther
Xora Innovation—
Angelini VenturesVenture capital
ClavystBioOther
Coronet Ventures—
EVX Ventures—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nuevocor investors

12 investors are on record for Nuevocor, including EDBI, SEEDS Capital, Highlight Capital and Kurma Partners.

Free account
More of Nuevocor with a free account
  • ·The complete investor list: 12 names
  • ·Watch Nuevocor: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Nuevocor. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View